Industry Perspectives

Shimadzu launches Nexera X4 UHPLC for ultra-fast, high-sensitivity analysis

The next-generation UHPLC system cuts analysis times by up to 92 percent while delivering up to 14 times greater laboratory productivity.
Written byShimadzu Scientific Instruments
| 2 min read
The Nexera X4 UHPLC

Credit: Shimadzu

Register for free to listen to this article
Listen with Speechify
0:00
2:00

COLUMBIA, Md — April 23, 2026 — Shimadzu Scientific Instruments introduces the Nexera X4 Ultra High-Performance Liquid Chromatograph (UHPLC), a next-generation system that builds on the proven technology of Shimadzu’s Nexera series. With its industry-leading low-dispersion design, the Nexera X4 UHPLC delivers superior sensitivity, ultra-sharp peaks, and outstanding separation performance. Advanced fluid control technology maintains exceptional flow stability during high-speed, ultra-high-pressure analyses for consistently reliable results. The system is ideal for research and development applications in pharmaceuticals, food, environmental science and chemistry.

Features of the Nexera X4 UHPLC include:

  • Ultra-Fast Analysis

With its new four-drive binary pump, independently activated plungers and pressure feedback control, the Nexera X4 UHPLC enables ultra-fast analysis through highly responsive solvent delivery. The instrument cuts analysis times by 92 percent versus typical HPLC systems and 78 percent versus other UHPLC-class systems, delivering up to 14 times greater laboratory productivity.

  • Ultra-Sharp Peaks

The Nexera X4 incorporates Shimadzu’s Nexflow technology to minimize system-derived peak broadening through low-dispersion flow paths that maintain the internal diameter of the flow lines. This feature increases sensitivity, enables full UHPLC column performance and delivers higher separation efficiency.

  • Ultra-Low Solvent Consumption

Used with narrow-bore columns, the Nexera X4 UHPLC significantly reduces solvent consumption, enabling more cost-efficient and environmentally conscious analysis.

  • Optimized for Analytical Miniaturization

The Nexera X4 UHPLC supports analytical miniaturization through its precise micro-volume injection, accurate mobile phase delivery and low-dispersion flow paths that minimize band broadening, even with narrow-bore columns.

  • Maximize Mass Spectrometry Performance

The Nexflow Tubing kit reduces peak broadening between the column outlet and MS interface, leveraging the ultra-fast and high-separation performance of the Nexera X4 UHPLC and maximizing mass spectrometer performance.

  • A Next-Generation LCMS Platform

Paired with Shimadzu’s triple quad LCMS-TQ RX Series systems, the Nexera X4 UHPLC delivers high-speed, high-sensitivity LC-MS/MS analysis. With UFswitching technology, the LCMS-TQ RX Series supports positive and negative ionization switching in just five msec, minimizing ion intensity loss and enabling stable, high-sensitive results. Combined with the Nexera X4’s excellent gradient control, the system offers exceptional throughput for demanding analytical workflows.

For more details, visit the Nexera X4 web page: https://www.ssi.shimadzu.com/products/liquid-chromatography/hplcuhplc/nexera-x4/index.html

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
3D illustration of a protein complex composed of clustered spherical subunits arranged in a ring-like oligomeric structure, shown in shades of blue, cyan, and purple against a blue gradient background.
Automated mass photometry helps reveal the complex dynamics of protein oligomerization and the factors that govern protein assembly.
Illustration of translucent Y-shaped antibodies floating in a soft blue and green background, representing antibody research, development, and biomedical science.
Explore how antibody accessibility and custom development strategies can influence the pace and success of translational research.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue